Usefulness of preoperative serum calcitonin in patients with nodular thyroid disease without suspicious history or cytology for medullary thyroid carcinoma;Utilidade da calcitonina sérica pré-operatória em pacientes com doença nodular tireoidiana sem história ou citologia suspeitas para carcinoma medular de tireoide

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 57, Issue 4, 2013, Pages 312-316

  Rosário, Pedro Weslley ^a   Penna, Gustavo Cancela ^a   Brandão, Kamilla ^a   Souza, Bárbara Érika ^a  

^a Santa Casa de Belo Horizonte   (Brazil)

Author keywords

Calcitonin; Medullary carcinoma; Nodular disease

Indexed keywords

BIOLOGICAL MARKER; CALCITONIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; LUMINESCENCE; MALE; MEDULLARY CARCINOMA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREOPERATIVE CARE; THYROID NODULE; THYROID TUMOR; THYROIDECTOMY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BIOPSY, FINE-NEEDLE; CALCITONIN; CARCINOMA, MEDULLARY; CHILD; FEMALE; HUMANS; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; PREOPERATIVE CARE; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; YOUNG ADULT;

EID: 84880017503     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302013000400006     Document Type: Article

References (23)

1. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit J, Wiersinga W. European Consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787-803.
2. Camargo R, Corigliano S, Friguglietti C, Gauna A, Harach R, Munizaga F, et al. Latin American Thyroid Society recommendations for the management of thyroid nodules. Arq Bras Endocrinol Metab. 2009;53:1167-75.
3. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2010;16(Suppl 1):1-43.
4. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19:565-612.
5. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-214.
6. Henry JF, Denizot A, Puccini M, Gramatica L, Kvachenyuk A, Conte Devolx B, et al. Latent subclinical medullary thyroid carcinoma: diagnosis and treatment. World J Surgery. 1998;22:752-6.
7. Bugalho MJ, Santos JR, Sobrinho L. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol. 2005;91:56-60.
8. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab. 2004;89:163-8.
9. Chambon G, Alovisetti C, Idoux-Louche C, Reynaud C, Rodier M, Guedj AM, et al. The Use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disordes: results from 2733 consecutive patients. J Clin Endocrinol Metab. 2011;96:75-81.
10. Niccoli P, Wion-Barbot N, Caron P, Henry JF, De Micco E, SaintAndre JP, et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J Clin Endocrinol Metab. 1997;82:338-41.
11. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab. 2007;92:450-5.
12. Scheuba C, Kaserer K, Moritz A, Drosten R, Vierhapper H, Bieglmayer C, et al. Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr Relat Cancer. 2009;16:243-53.
13. Colombo C, Verga U, Mian C, Ferrero S, Perrino M, Vicentini L, et al. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab. 2012;97:905-13.
14. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S. Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitoninin patients with thyroid disorders. Thyroid. 2005;15:1267-72.
15. Iacobone M, Niccoli-Sire P, Sebag F, DeMicco C, Henry JF. Can sporadic Medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg. 2002;26:886-90.
16. Gibelin H, Essique D, Jones C, Levillain P, Maréchaud R, Kraimps JL. Increased calcitonin level in thyroid nodules without medullary carcinoma. Br J Surg. 2005;92:574-8.
17. Papi G, Corsello SM, Cioni K, Pizzini AM, Corrado S, Carapezzi C, et al. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study. J Endocrinol Invest. 2006;29:427-37.
18. Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Vierhapper H, Haas OA, et al. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serumcalcitonin. Am J Surg Pathol. 1998;22:722-8.
19. Machens A, Hoffmann F, Sekulla C, Dralle H. Importance of genderspecific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer. 2009;16:1291-8.
20. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab. 1994;78:826-9.
21. Herrmann BL, Schmid KW, Goerges R, Kemen M, Mann K. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease. Eur J Endocrinol. 2010;162:1141-5.
22. Rink T, Truong PN, Schroth HJ, Diener J, Zimny M, Grunwald F. Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid. 2009;19:327-32.
23. Doyle P, Duren C, Nerlich K, Verburg FA, Grelle I, Jahn H, et al. Potency and tolerance of calcitonin stimulation with high-dose calcium vs. pentagastrin in normal adults. J Clin Endocrinol Metab. 2009; 94:2970-4.